Isotechnika Pharma Inc IPHAF

good morning just read the day well!

[sam00122]

Good morning and i think it is going to be.   I have been reading all your coments.  There are alot of interesting discussion going on here.  I do agree that i think TV has a hidden ajenda but, I try to take all he says with a grain of sait.   I just want to add a comment.  ! I am a long term investor and I would say that I have read 99.9 % of all the news on this company and the drug 247,  Roche will opt in because the renegotiaon  stated that ISA had to get 247 past the IIb renel kidley tranplant step and @ that point roche will opt in and take over the cost of the phase III trails and all other cost untill 247 come to market for transplantation,  I need to ask how many poeple believe here that if i can take a drug over the counter for a skin deseace and  it doesn"t destroy my kidleys. then I would think that the same drug being used in a differnet market would still be able to take the results from the set of skin deseace patients and use the information to identifiy that the transplant patients are no differnt, other than dosage.  In my opinion ISA did the best thing when they figured out that 247 was good for other medicial problem and I think Roche was happy with the idea because they could watch and see the drug proved through skin deseace and the risk would be alot lower for them if drug didn't stand up.  So the drug she done stood up but, she a lot big than they are giving her right now.  That will change hopfully beginning today